We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+23.53%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$221M
AUM Growth
+$50.5M
Cap. Flow
+$20.5M
Cap. Flow %
9.26%
Top 10 Hldgs %
55.64%
Holding
119
New
19
Increased
16
Reduced
14
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 36.46%
2 Financials 19.6%
3 Materials 10%
4 Technology 8.95%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$951B
$2.54M 1.15%
19,970
-3,080
-13% -$344K
AUPH icon
27
Aurinia Pharmaceuticals
AUPH
$2.17B
$2.46M 1.11%
177,540
+42,940
+32% +$625K
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
$2.25M 1.02%
112,707
MPLX icon
29
MPLX
MPLX
$60.1B
$2.17M 0.98%
100,000
HZAC
30
DELISTED
Horizon Acquisition Corporation
HZAC
$2.1M 0.95%
+210,100
New +$2.11M
JOBY icon
31
Joby Aviation
JOBY
$6.9B
$2.04M 0.92%
+176,226
New +$1.96M
BRSL
32
Brightstar Lottery PLC
BRSL
$2.11B
$1.82M 0.82%
107,500
CHRS icon
33
Coherus Oncology
CHRS
$218M
$1.77M 0.8%
101,655
+2,162
+2% +$38.5K
AB icon
34
AllianceBernstein
AB
$3.43B
$1.71M 0.77%
50,500
ALXN
35
DELISTED
Alexion Pharmaceuticals
ALXN
$1.65M 0.75%
10,545
-1,455
-12% -$187K
BCRX icon
36
BioCryst Pharmaceuticals
BCRX
$2.51B
$1.64M 0.74%
219,461
-177,900
-45% -$917K
BDSI
37
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.55M 0.7%
370,230
-111,700
-23% -$430K
VAPO
38
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.32M 0.6%
6,125
QURE icon
39
uniQure
QURE
$3.38B
$1.26M 0.57%
35,000
+4,000
+13% +$169K
VKTX icon
40
Viking Therapeutics
VKTX
$3.75B
$1.23M 0.56%
218,102
VZ icon
41
Verizon
VZ
$208B
$1.08M 0.49%
18,311
JNJ icon
42
Johnson & Johnson
JNJ
$646B
$956K 0.43%
6,080
-1,200
-16% -$177K
CNST
43
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$950K 0.43%
+33,000
New +$831K
MDLZ icon
44
Mondelez International
MDLZ
$79.6B
$930K 0.42%
15,900
VRCA icon
45
Verrica Pharmaceuticals
VRCA
$97.7M
$881K 0.4%
7,659
+3,046
+66% +$280K
DD icon
46
DuPont de Nemours
DD
$18.5B
$861K 0.39%
9,654
RHP icon
47
Ryman Hospitality Properties
RHP
$8.92B
$840K 0.38%
12,400
CDTX
48
DELISTED
Cidara Therapeutics
CDTX
$831K 0.38%
20,765
+412
+2% +$20.5K
KMB icon
49
Kimberly-Clark
KMB
$36.4B
$809K 0.37%
6,000
KO icon
50
Coca-Cola
KO
$386B
$735K 0.33%
13,400

Similar funds

David M. Knott's Q4 2020 Portfolio in Review

As of Q4 2020, David M. Knott held 119 positions worth $221M, up 30% from $170M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott deployed $20.5M of net new capital in Q4 2020, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.71M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was LKQ Corp, an estimated $1.03M trimmed.

  • David M. Knott's largest Q4 2020 buy was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.71M.
  • David M. Knott added most to Gilead Sciences in Q4 2020, an estimated $3.25M increase.
  • David M. Knott's biggest Q4 2020 reduction was LKQ Corp, cutting an estimated $1.03M.
  • David M. Knott fully exited Stericycle Inc in Q4 2020, selling an estimated $10.1M.
  • David M. Knott's ten largest holdings make up 56% of its $221M portfolio in Q4 2020.
  • David M. Knott opened 19 new positions and closed 9 in Q4 2020.
  • David M. Knott's portfolio value rose 30% quarter-over-quarter to $221M.

Based on David M. Knott's 13F filing for Q4 2020, filed 12 Feb 2021.